Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice

Biology of Reproduction

Volumn 76, Issue 5, 2007, Pages 738-748

  Robertson, Sarah A ^a   Care, Alison S ^a   Skinner, Rebecca J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cytokines; Immunology; Placenta; Pregnancy; Uterus

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ETANERCEPT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT CYTOKINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FETUS; FETUS GROWTH; FETUS WASTAGE; GENE; GENE EXPRESSION REGULATION; GENOTYPE PHENOTYPE CORRELATION; GESTATION PERIOD; IL6 GENE; IMMUNOMODULATION; IMMUNOREGULATION; INDUCED ABORTION; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TNFA GENE; UTERUS;

ABORTION, SPONTANEOUS; ANIMALS; BIRTH WEIGHT; CYTOKINES; DNA PRIMERS; FEMALE; FETAL GROWTH RETARDATION; IMMUNOASSAY; IMMUNOGLOBULIN G; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; ORGAN SIZE; PREGNANCY; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UTERUS;

MUS;

EID: 34247478549     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.106.056143     Document Type: Article

References (62)

1. Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003; 9:163-174.
2. Thellin O, Coumans B, Zorzi W, Igout A, Heinen E. Tolerance to the foeto-placental 'graft': ten ways to support a child for nine months. Curr Opin Immunol 2000; 12:731-737.
3. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006; 7:241-246.
4. Croy BA, Chantakru S, Esadeg S, Ashkar AA, Wei Q. Decidual natural killer cells: key regulators of placental development (a review). J Reprod Immunol 2002; 57:151.
5. Christiansen OB, Nielsen HS, Kolte AM. Inflammation and miscarriage. Semin Fetal Neonatal Med 2006; 11:302-308.
6. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV, McNellis D, Regan JA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995; 333:1737-1742.
7. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994; 15:819-835.
8. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42:1-8.
9. Gendron RL, Nestel FP, Lapp WS, Baines MG. Lipopolysaccharide-induced fetal resorption is associated with the intrauterine production of tumor necrosis factor-a. J Reprod Fertil 1990; 90:395-402.
10. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA. Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothombinase. J Immunol 1998; 160:545-549.
11. Tangri S, Raghupathy R. Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod 1993; 49:850-856.
12. Erlebacher A, Zhang D, Parlow AF, Glimcher LH. Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system. J Clin Invest 2004; 114:39-48.
13. Arck PC, Merali FS, Manuel J, Chaouat G, Clark DA. Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factor-alpha (TNF-alpha) release as a mechanism triggering resorptions in mice. Am J Reprod Immunol 1995; 33:74-80.
14. Lea RG, McIntyre S, Baird JD, Clark DA. Tumor necrosis factor-alpha mRNA-positive cells in spontaneous resorption in rodents. Am J Reprod Immunol 1998; 39:50-57.
15. Pampfer S. Dysregulation of the cytokine network in the uterus of the diabetic rat. Am J Reprod Immunol 2001; 45:375-381.
16. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG. Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89:447-458.
17. Knackstedt MK, Zenclussen AC, Hertwig K, Hagen E, Dudenhausen JW, Clark DA, Arck PC. Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion. Am J Reprod Immunol 2003; 49: 210-220.
18. Arck PC, Troutt AB, Clark DA. Soluble receptors neutralizing TNF-alpha and IL1 block stress-triggered murine abortion. Am J Reprod Immunol 1997; 37:262-266.
19. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interieukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
20. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
21. Chaouat G, Cayol V, Mairovitz V, Dubanchet S. Localisation of the Th2 cytokines IL-3, IL-4, IL10 at the murine feto-maternal interface during pregnancy. In: Gupta SK (ed.), Reproductive Immunology. New Delhi: Narosa; 1999:61-70.
22. Sallinen K, Verajankorva E, Pollanen P. Expression of antigens involved in the presentation of lipid antigens and induction of clonal anergy in the female reproductive tract. J Reprod Immunol 2000; 46:91-101.
23. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184:539-548.
24. Trautman MS, Collmer D, Edwin SS, White W, Mitchell MD, Dudley DJ. Expression of interleukin-10 in human gestational tissues. J Soc Gynecol Investig 1997; 4:247-253.
25. Heyborne KD, McGregor JA, Henry G, Witkin SS, Abrams JS. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994; 171: 55-59.
26. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr, Bennett WA. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181:915-920.
27. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998; 4:1020-1024.
28. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993; 75:263-274.
29. Svensson L, Arvola M, Sallstrom MA, Holmdahl R, Mattsson R. The Th2 cytokines IL-4 and IL10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol 2001; 51:3-7.
30. White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA. Effect of interieukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod 2004; 70:123-131.
31. Murphy SP, Fast LD, Hanna NN, Sharma S. Uterine NK cells mediate inflammation-induced fetal demise in IL10-null mice. J Immunol 2005; 175:4084-4090.
32. Robertson SA, Skinner RJ, Care AS. Essential role for interieukin-10 in resistance to LPS-induced preterm labour in mice. J Immunol 2006; 177: 4888-4896.
33. Rivera DL, Olister SM, Liu X, Thompson JH, Zhang XJ, Pennline K, Azuero R, Clark DA, Miller MJ. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J 1998; 12:189-197.
34. Terrone DA, Rinehart BK, Granger JP, Barrilleaux PS, Martin JN Jr, Bennett WA. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol 2001; 98:476-480.
35. Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliot J, Mosmann T, Wegmann TG. IL10 prevents naturally occurring fetal loss in the CBA x DBA/2 mating combination, and local defect in IL10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol 1995; 154:4261-4268.
36. Rijhsinghani AG, Thompson K, Tygrette L, Bhatia SK. Inhibition of interleukin-10 during pregnancy results in neonatal growth retardation. Am J Reprod Immunol 1997; 37:232-235.
37. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 1995; 96:2339-2347.
38. Matthews N, Neale ML. Cytotoxicity assays for tumor necrosis factor and lymphotoxin. In: Clemens MJ, Morris AG, Gearing AJH (eds.), Lymphokines and Interferons: A Practical Approach. Oxford: IRL Press; 1987:221-225.
39. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Friers W, Goldman M, Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177:547-550.
40. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177:1205-1208.
41. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993; 151:1548-1561.
42. Wooley PH, Dutcher J, Widmer MB, Gillis S. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 1993; 151:6602-6607.
43. Lukacs NW, Strieter RM, Chensue SW, Widmer M, Kunkel SL. TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 1995; 154:5411-5417.
44. Kohmura Y, Kirikae T, Kirikae F, Nakano M, Sato I. Lipopolysaccharide (LPS)-induced intra-uterine fetal death (IUFD) in mice is principally due to maternal cause but not fetal sensitivity to LPS. Microbiol Immunol 2000; 44:897-904.
45. Xu DX, Chen YH, Wang H, Zhao L, Wang JP, Wei W. Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced intra-uterine fetal growth restriction and skeletal development retardation in mice. Toxicol Lett 2006; 163:20-29.
46. Zenclussen AC, Blois S, Stumpo R, Olmos S, Arias K, Malan Borel I, Roux ME, Margni RA. Murine abortion is associated with enhanced interleukin-6 levels at the feto-maternal interface. Cytokine 2003; 24:150-160.
47. Gutierrez G, Sarto A, Berod L, Canellada A, Gentile T, Pasqualini S, Margni RA. Regulation of interleukin-6 fetoplacental levels could be involved in the protective effect of low-molecular weight heparin treatment on murine spontaneous abortion. Am J Reprod Immunol 2004; 51:160-165.
48. Tilg H, Dinarello CA, Mier JW. IL6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997; 18:428-432.
49. Bemelmans MH, Gouma DJ, Buurman WA. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL1, leukemia inhibiting factor, and IFN-gamma. J Immunol 1993; 151:5554-5562.
50. Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994; 24:1167-1171.
51. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177:547-550.
52. Haddad EK, Duclos AJ, Lapp WS, Baines MG. Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua. J Immunol 1997; 158:4886-4892.
53. Haddad EK, Duclos AJ, Antecka E, Lapp WS, Baines MG. Role of interferon-gamma in the priming of decidual macrophages for nitric oxide production and early pregnancy loss. Cell Immunol 1997; 181:68-75.
54. Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL10 on lipopolysaccharide-induced macrophage activation. J Immunol 2002; 168:6404-6411.
55. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL10 in human macrophages. J Immunol 2004; 172:567-576.
56. Shibata Y, Foster LA, Kurimoto M, Okamura H, Nakamura RM, Kawajiri K, Justice JP, Van Scott MR, Myrvik QN, Metzger WJ. Immunoregulatory roles of IL10 in innate immunity. IL10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J Immunol 1998; 161:4283-4288.
57. Barker DJ, Clark PM. Fetal undernutrition and disease in later life. Rev Reprod 1997; 2:105-112.
58. Hales CN, Ozanne SE. The dangerous road of catch-up growth. J Physiol 2003; 547:5-10.
59. Roberts CT, White CA, Wiemer NG, Ramsay A, Robertson SA. Altered placental development in interleukin-10 null mutant mice. Placenta 2003; 24(suppl A):S94-S99.
60. Myatt L. Control of vascular resistance in the human placenta. Placenta 1992; 13:329-341.
61. Suffredini AF, Reda D, Banks SM, Tropea M, Agosti JM, Miller R. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol 1995; 155:5038-5045.
62. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy - review of a new approach. Pharmacol Rev 2003; 55:241-269.